Urs Schwitter
21Patents
2h-index
59Co-inventors
60Inventor score
Filing activity: Jan 27, 2004 → Oct 11, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8865735B2 | Solid forms of a pharmaceutically active substance | Human Necessities | 53 | Active |
| US7409041B2 | Methods of transmission mode X-ray diffraction analysis and apparatuses therefor | Physics | 3 | Expired |
| US9676793B2 | Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same | Chemistry; Metallurgy | 2 | Active |
| US11230559B2 | Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate | Chemistry; Metallurgy | 2 | Active |
| US10221125B2 | Solid forms | Chemistry; Metallurgy | 1 | Active |
| US10246460B2 | Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof | Chemistry; Metallurgy | 1 | Active |
| US8039473B2 | Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone | Human Necessities | 1 | Active |
| US11814354B2 | Solid forms | Chemistry; Metallurgy | 1 | Active |
| US9562009B2 | Process to manufacture N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide | Chemistry; Metallurgy | 0 | Active |
| US12134599B2 | Solid forms | Chemistry; Metallurgy | 0 | Active |
| US8975397B2 | Solid forms | Human Necessities | 0 | Active |
| US12012421B2 | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate | Chemistry; Metallurgy | 0 | Active |
| US10227298B2 | Solid forms of a pharmaceutically active compound | Chemistry; Metallurgy | 0 | Active |
| US8748455B2 | Solid forms of a pharmaceutically active substance | General | 0 | Revoked |
| US12122789B2 | Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making | Chemistry; Metallurgy | 0 | Active |
| US10919041B2 | Preparing and analyzing solid form properties of a substance | Performing Operations; Transporting | 0 | Active |
| US7772264B2 | Salt and polymorphs of a DPPIV inhibitor | Human Necessities | 0 | Active |
| US12012420B2 | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate | Chemistry; Metallurgy | 0 | Active |
| US8785435B2 | Solid forms | Human Necessities | 0 | Active |
| US7160881B2 | Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 λ6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide | Human Necessities | 0 | Expired |
| US11040977B2 | Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.